Log in

Biotech - News Headlines

Corporate news news icon
| November 24th, 2019  5:06 PM
Novartis to buy The Medicines Company for $9.7 billion
Swiss pharmaceutical company Novartis has reached a deal to buy cholesterol drugmaker The Medicines Co. for $9.7 billion. Novartis will pay $85 per share for the New Jersey biotech company, a sharp increase over The Medicine Co.’s Friday closing price of $68.55 per share. The deal is worth $9.7 billion, including outstanding stock options and convertible debt. The Medicines Co.
Read Article
Government and politics news icon
Court OKs conviction of pharma executive Shkreli's ex-lawyer
October 30th, 2019  11:50 AM

An appeals court in New York says the former lawyer of a notorious pharmaceutical executive was properly convicted in a financial fraud case

Economy news icon
US stock indexes waver on mixed company earnings
October 22nd, 2019  3:42 PM

The major U.S. stock indexes wavered between small gains and losses in late-afternoon trading Tuesday as investors weighed a mixed batch of earnings reports from McDonald's, Procter & Gamble and other big companies.

Economy news icon
US stock indexes edged mostly higher on company earnings
October 22nd, 2019  2:13 PM

Major U.S. stock indexes are edging mostly higher in afternoon trading as investors weigh a mixed batch of company earnings reports

Financial markets news icon
US stocks edge higher on company earnings; Biogen surges
October 22nd, 2019  10:30 AM

Stocks edged higher in early trading following several positive earnings reports from US companies, holding the S&P 500 above 3,000 and within range of its all-time high set on July 26.

Restaurants could be 1st to get genetically modified salmon
Restaurants could be 1st to get genetically modified salmon
June 21st, 2019  1:11 AM

Restaurants could be among the first in the U.S. to serve genetically modified salmon

Pfizer
Pfizer to buy Array BioPharma in deal worth $11.4 billion
June 17th, 2019  8:28 AM

Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion

Donald Trump
Trump orders simpler path for genetically engineered food
June 11th, 2019  7:13 PM

President Trump has signed an executive order directing federal agencies to simplify the regulatory process for genetically engineered plants and animals

Bioengineered salmon won't come from US's biggest farm state
Bioengineered salmon won't come from US's biggest farm state
June 9th, 2019  8:32 AM

Genetically engineered salmon is headed to store shelves in the U.S., but it won't be coming from the biggest salmon farming state in the country

At $2M, priciest ever medicine treats fatal genetic disease
At $2M, priciest ever medicine treats fatal genetic disease
May 24th, 2019  5:51 PM

U.S. regulators have approved the most expensive medicine ever, a $2.125 million gene therapy meant to cure a disorder that rapidly destroys a baby's muscle control and kills most within a couple years

Government and politics news icon
FDA approves $2M medicine, most expensive ever
May 24th, 2019  4:26 PM

U.S. regulators have approved the most expensive medicine ever, a $2.125 million gene therapy meant to cure a disorder that rapidly destroys a baby's muscle control and kills most within a couple years

Corporate news news icon
FDA okays $2M medicine, most expensive ever
May 24th, 2019  1:41 PM

U.S. regulators have approved the most expensive medicine ever, a $2.125 million gene therapy meant to cure a disorder that rapidly destroys a baby's muscle control and kills most within a couple years

Science Says: Why scientists prize plant, animal genomes
Science Says: Why scientists prize plant, animal genomes
March 29th, 2019  12:36 PM

For scientists, finding an animal's DNA code opens the door to discoveries

Technology news icon
Science Says: Why scientists prize plant, animal genomes
March 29th, 2019  11:25 AM

For scientists, finding an animal's DNA code opens the door to discoveries

Consumer products and services news icon
Stocks move broadly higher, led by technology companies
March 21st, 2019  11:27 AM

U.S. stocks move higher as gains by Apple and other technology companies offset declining banks

Gene-edited food quietly arrives in restaurant cooking oil
Gene-edited food quietly arrives in restaurant cooking oil
March 12th, 2019  4:46 PM

A Midwestern restaurant is using cooking oil made from soybeans gene edited to be healthier and longer lasting

US regulators clear path for genetically modified salmon
US regulators clear path for genetically modified salmon
March 8th, 2019  10:06 PM

Genetically modified salmon have cleared another hurdle to be sold in the U.S., but could still face legal challenges

Leading economic indicators news icon
Stocks slide as investors wait for details on trade talks
March 4th, 2019  3:07 PM

Health care companies are leading a broad slide on Wall Street as investors wait for more details on reports that the U.S. and China are moving closer to a deal to resolve their costly trade dispute

Government policy news icon
Stocks slump as investors wait for details on trade talks
March 4th, 2019  1:43 PM

Stocks are broadly lower on Wall Street, knocking more than 300 points off the Dow Jones Industrial Average

Leading economic indicators news icon
Stocks fall as investors wait for details on trade talks
March 4th, 2019  12:16 PM

Stocks edge lower in afternoon trading on Wall Street as investors wait for more details about trade talks between the U.S. and China

Government policy news icon
As hope grows for China trade deal, US stocks edge higher
March 4th, 2019  10:57 AM

US stocks are edging higher in morning trading over optimism for US-China trade deal

Hope for US-China deal pushes stocks higher
Hope for US-China deal pushes stocks higher
March 4th, 2019  10:06 AM

US stocks move broadly higher in early trading over optimism for US-China trade deal

GE sells biopharma unit for $21 billion
GE sells biopharma unit for $21 billion
February 25th, 2019  8:29 AM

General Electric to sell biopharma business to Danaher Corp. for $21.4 billion

News Icon
General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations
February 25th, 2019  7:11 AM

General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations

Energy industry news icon
Stocks climb as investors hope for Trump-Xi trade progress
November 30th, 2018  5:21 PM

After a shaky start, stocks finish with strong gains ahead of the highly anticipated meeting between President Donald Trump and Chinese President Xi Jinping

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel